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Purpose: Axenfeld-Rieger syndrome (ARS) is an autosomal dominant disorder characterized by extraocular anomalies
and developmental defects of the anterior segment. PITX2 (paired-like homeodomain transcription factor 2) is considered
the major causative gene. In this study, we characterized the molecular defect in PITX2 in a Chinese family with ARS.
Methods: Two generations of the family with ARS were enrolled in the present study. In addition to ophthalmologic
examinations, polymerase chain reaction (PCR) amplification and nucleotide sequencing of all coding exons of PITX2
were performed. Exon 5 (region 1) was also sequenced in 100 healthy controls unrelated to the family for comparison.
Results: A novel PITX2 mutation, c.840G>T, was identified in all affected members of the family with ARS that causes
an amino acid substitution from tryptophan to cysteine at codon 86.
Conclusions: We found a novel p.W86C mutation in PITX2 in a Chinese family with ARS. The tryptophan residue at
position 86 is strictly conserved in PITX2a proteins from several species and in homeodomain proteins. We suggest that
this mutation in PITX2 is the cause of typical ARS in patients. Our results may be useful for better understanding of the
spectrum of PITX2 mutations and the role of PITX2 in the development and progression of ARS.
Axenfeld-Rieger syndrome (ARS; OMIM 180500) is a
rare  multisystem  autosomal  dominant  disorder,  which  is
characterized  by  complete  penetrance  but  variable
expressivity [1]. ARS encompasses several conditions with
overlapping  phenotypes  including  Rieger  syndrome,
Axenfeld anomaly, and Rieger anomaly [2,3]. The classic
ocular defects of ARS include iris hypoplasia, iridocorneal
adhesion, corectopia, polycoria, posterior embryotoxon, and
other  less  frequent  features  such  as  cataracts,  retinal
detachment,  and  microcornea  [4,5].  Systemic  anomalies
associated  with  ARS  include  facial  malformation
(telecanthus, maxillary hypoplasia with protruding lower lip),
dental  abnormalities,  and  redundant  periumbilical  skin.
Approximately half of the individuals affected with ARS also
develop glaucoma [2,3].
The incidence of ARS is estimated to be approximately
1:200,000 births [6]. Mutations in several chromosomal loci
have been implicated in ARS including PITX2 (paired-like
homeodomain transcription factor 2; 4q25; OMIM 601542),
FOXC1  (forkhead  box  C1;  6p25; OMIM  601090),  PAX6
(paired box gene 6; 11p13; OMIM 607108) and MAF (v-MAF
avian musculoaponeurotic fibrosarcoma oncogene homolog;
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16q24; OMIM 177075). A yet to be identified gene at 13q14
(OMIM 601499) may also be found involved in ARS [7-11].
Full-spectrum ARS is caused primarily by mutations in
PITX2 [1]. PITX2 is a member of the bicoid-like homeobox
transcription factor family [7]. The homeobox gene family
members play fundamental roles in the genetic control of
development,  particularly  in  pattern  formation  and  the
determination of cell fate [12-14]. PITX2 contains a 60 amino
acid  homeodomain  with  a  lysine  at  residue  50  that  is
characteristic  of  the  bicoid-related  proteins  [15-17].  Its
expression in neural crest cells is necessary for optic stalk and
anterior  segment  structure  development  [18].  PITX2  is
produced as at least four different transcriptional and splicing
isoforms, PITX2a, b, c, and d, which have different biological
properties  [19].  PITX2a,  PITX2b,  and  PITX2c  isoforms
contain  the  same  homeodomain  and  COOH-terminus  but
differ  at  the  NH2-terminus.  The  PITX2d  isoform  has  a
truncated, nonfunctional homeodomain [19]. Although the
role of PITX2 in the pathogenesis of ARS has yet to be clearly
defined,  a  deficiency  in  normal  PITX2  protein
(haploinsufficiency)  is  suggested  to  be  one  of  the  major
molecular mechanisms for the development of ARS [20,21].
Except a few intronic mutations [22,23], most of the mutations
detected  in  human  PITX2  are  point  mutations  in  the
homeodomain  or  COOH-terminal  domains.  A  correlation
between the severity of ARS phenotypes and the levels of
normal PITX2 protein was also noted [24-26]. In the present
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2205study, we analyzed the PITX2a isoform for mutations in a
family affected by ARS.
ARS is relatively rare in China. The purpose of this study
was to describe the clinical and molecular characteristics of a
northeastern  Chinese  family  affected  by  Axenfeld-Rieger
syndrome (ARS).
METHODS
Study participants: We studied two generations of a Chinese
family with a history of Axenfeld-Rieger syndrome (ARS)
from the Heilongjiang province in northeastern China (Figure
1). Three patients, three non-carrier relatives, and 100 healthy
normal controls were recruited for this study. The study was
approved  by  the  Institutional  Review  Board  of  Harbin
Medical University and informed consent was obtained from
each  of  the  participants.  All  subjects  underwent  full
ophthalmologic  examination  including  visual  acuity,  slit
lamp,  funduscopy,  gonioscopy,  and  the  measurement  of
intraocular pressure (IOP).
Figure 1. Pedigree of a family with Axenfeld-Rieger syndrome.
Autosomal dominant transmission of the disease is evident. The
asterisks indicate subjects who underwent clinical and molecular
analysis.  Black  symbols  represent  affected  members.  The  arrow
signals the proband.
Genetic  analysis:  Blood  samples  were  drawn  by
venipuncture,  and  genomic  DNA  was  extracted  using  the
TIANamp Blood DNA Kit (Tiangen Biltech Co. Ltd, Beijing,
China).  All  coding  exons  of  PITX2  were  amplified  by
polymerase  chain  reaction  (PCR)  using  specific  primers
(Table 1). The primers for exons 3-5 were adapted from those
described by Cella and coworkers [27]. The PCR fragments
were purified with a TIANgel Midi Purification Kit (Tiangen
Biltech  Co.  Ltd)  and  sequenced  with  an  ABI  BigDye
Terminator  Cycle  Sequencing  kit  v3.1,  (ABI  Applied
Biosystems, Foster City, CA).
RESULTS
PITX2 mutation analysis: After direct sequencing of PITX2,
a single heterozygous G to T mutation at nucleotide position
840 of PITX2 was detected (Figure 2) in all affected members.
This resulted in a W86C mutation (tryptophan to cysteine
substitution) at the protein level. None of the healthy family
Figure 2. Partial nucleotide sequence of PITX2. A: The sequence in
an  affected  subject  shows  a  heterozygous  G>T  transversion
(indicated by the arrow). The nucleotide substitution at codon 86
results in a change from tryptophan to cysteine. B: Unaffected family
members and the general population lack this nucleotide change.
TABLE 1. PRIMER SEQUENCES AND THE SIZES OF THEIR CORRESPONDING PCR PRODUCTS.
PITX2 exon Sequences (5′-3′) Amplicon (bp)
PITX2-exon 1 F: CCGCTTCTTACAGCCTTCCT 247
  R: CTGGCGATTTGGTTCTGATT
PITX2-exon 2 F: TGGGTCTTTGCTCTTTGTCC 400
  R: GCGGAGTGTCTAAGTTCAAGC
PITX2-exon 3 F: GGGGCAGTAGCCAAGGACT 289
  R: CAGCTAAGCGGGAATGTCTG
PITX2-exon 4 F: GGCATGCTGACGGGAAAG 300
  R: CTGTACCTCCACAACATCCTC
PITX2-exon 5 (region 1) F: CACTGTGGCATCTGTTTGCT 324
  R: GGACGACATGCTCATGGAC
PITX2-exon 5 (region 2) F: TATGAACGTCAACCCCCTGT 400
  R: CCATCCGGCAAGGTCCTA
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this mutation.
Clinical findings: The proband (II:7) was 26 years old. He had
experienced  defective  vision  since  childhood.  His  visual
acuity was 20/100 in the right eye and counting fingers in the
left eye. Although both eyes were affected, the clinical aspects
of his eyes were different. In the right eye, ocular examination
displayed corectopia associated with partial aniridia and iris
hypoplasia (Figure 3A). Funduscopy showed glaucomatous
atrophy  of  the  optic  nerve,  and  the  IOP  was  30  mmHg.
External examination of the left eye showed displaced pupils
along with iris atrophy, polycoria, and congenital cataract
(Figure 3B). The complete cataract prevented ocular fundus
examination.  The  IOP  was  26  mmHg.  In  addition  to  the
various ocular abnormalities, posterior embryotoxon was also
found in both eyes following gonioscopic examination. Non-
ocular abnormalities of the proband consisted of characteristic
facial  features  with  telecanthus,  a  thin  upper  lip,  and  a
protruding lower lip (Figures 3D,E). In addition to redundant
periumbilical skin, dental anomalies were also present (Figure
3C,D).
Individual II:1, 32 years old, is one of the proband’s
sisters. Ocular examination of the right eye showed corectopia
and iris hypoplasia. In the left eye, only mild iris hypoplasia
was detected. She had posterior embryotoxon in each eye, but
the fundus and IOP was normal. The non-ocular abnormalities
included  dental  anomalies  and  characteristic  redundant
periumbilical skin. Her daughter, III:1, was nine years old.
She had a bilateral posterior embryotoxon unaccompanied by
any other ocular abnormality. She had normal teeth but had
redundant  periumbilical  skin.  Her  IOP  was  also  normal.
Individual III:2 who was another daughter of individual II:1,
individual II:5 who was another sister of the proband, and her
daughter, III:4, did not show any clinical sign of ARS and had
normal IOP.
DISCUSSION
In this study, we described a novel mutation (c.840G>T) in
PITX2a in a northeastern Chinese family with ARS. None of
the proband’s unaffected relatives exhibited the mutation.
PITX2a  is  a  33  kDa  homeodomain  protein.  The
homeodomain is responsible for recognizing specific DNA
sequences to bring the transcription factors to proper target
genes. This 60 amino acid domain is composed of three helices
and  a  flexible  NH2-terminal  arm  [13,28].  Its  integrity  is
essential for binding DNA and is critical for PITX2 to act as
a  transcription  factor.  The  third  helix  is  also  called  the
recognition helix, which is the site of DNA recognition and
binding, and is thought to fit into the major groove of DNA
and to establish contact with specific residues of the bicoid
binding sequence [13,28-30].
The  function  of  the  mutated  PITX2  proteins  can  be
analyzed in vitro through mutational and functional analyses.
Figure 3. Ocular characteristics and systemic anomalies of the proband with Axenfeld-Rieger syndrome. Slit lamp photographs are shown of
the proband showing iris hypoplasia and corectopia associated with partial aniridia in the right eye (A), and iris atrophy and polycoria along
with congenital cataract in the left eye (B). Systemic anomalies of the proband included redundant periumbilical skin (C), dental anomalies,
a protruding lower lip (D), and telecanthus (E).
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localization, DNA binding, and transactivation activity [31].
Thus far, several missense mutations resulting in single amino
acid substitutions within helix 3 of the PITX2a homeodomain
have been identified [7,24,32-34] (Figure 4), and these PITX2
mutations  alter  protein  function  to  varying  degrees.  For
example, the R84W mutant protein has a normal DNA binding
specificity and could transactivate the Dlx2 promoter [25].
However, the K88E mutation is defective in its capacity to
bind  DNA  and  transactivation  activity  [26,35].  In  2002,
Quentien et al. [36] demonstrated the R91P PITX2a mutation,
which  is  dominant  negative  but  can  still  bind  DNA.  The
potential disruption of the helix 3 structure in the R91P mutant
may affect the interaction of the factor with a limiting cofactor
when bound to DNA. Interestingly, Priston et al. [24] reported
the mutation, V83L, in PITX2a affects DNA binding and
transactivation  differently.  Its  mutation  results  in  reduced
DNA binding but also leads to a greater than 200% increase
in transactivation activity compared to wt PITX2.
The  specific  amino  acid  substitution,  a  change  from
tryptophan  to  cysteine,  described  in  the  present  paper
(p.W86C) occurs in the helix 3 of the homeodomain (Figure
4). The tryptophan residue at position 86 is strictly conserved
in PITX2a proteins from different species such as Xenopus
laevis, Mus musculus, Rattus norvegicus, Xenopus tropicalis,
Canis lupus familiaris, Pan Troglodytes, Gallus gallus, and
Bos Taurus (BLAST). Tryptophan residues are also conserved
in  other  homeodomain  proteins  such  as  antennapedia,
engrailed, and goosecoid. This high level of conservation
indicates that this region may be important for the structure
and/or function of the protein. Amino acid changes at this
particular residue also have been shown to have a disease-
causing effect in the case of the homeodomain transcription
factors, HLXB9 (Currarino syndrome), LMX1B (Nail-patella
syndrome),  and  PAX3  (Warrensburg  syndrome).  The
mutational effects may be a disruption of protein stability
[37].
In summary, we provide clinical and molecular evidence
supporting the occurrence of a novel p.W86C mutation to
PITX2a within a northeastern Chinese family with inherited
ARS. Our results may improve the understanding of the role
that PITX2 plays in ARS and helps expand the knowledge of
the genetic causes of anterior segment disorders.
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